Mood tracking is the latest wellness innovation, but happiness experts are conflicted about whether a wearable that logs your ...

According to Pharmarack, the structural shift in the IPM has become more pronounced, with chronic and sub-chronic therapies ...

Fitbit is moving its Gemini-powered personal health coach into its next phase, officially adding support for Canadian French ...

Following significant industry outcry over a proposal to keep Medicare Advantage rates largely flat in 2027, the Trump ...

Oil heads for biggest daily fall since pandemic as Iran says it will reopen strait of Hormuz under its management ...

US stocks surge on the week, but S&P 500 momentum fades Friday. CPI data, oil prices, and geopolitics drive cautious market ...

Nigeria's ongoing Lassa fever outbreak is showing a worrying rise in deaths, with new figures from treatment centres and ...

A conversation with two collaborators and friends of the eco-philosopher and teacher, who died in July 2025, reveals how ...

Avalyn Pharma's IPO aims to fund inhaled IPF therapies as AP01 shows positive Phase II results. Read the full analysis here.

We’re hoping you can come in early.” There are times I want to let these calls go to voicemail, but our group of ER ...

AstraZeneca is driven by a diversified portfolio, robust R&D, and strong FCF, despite a current valuation that is slightly ...

Data presented at the same congress reinforced cefiderocol's effectiveness against Stenotrophomonas maltophilia, with a subgroup analysis of 119 patients from the PROVE study demonstrating clinical ...